[Connatal endocrine disorders caused by receptor defects]

Klinische Padiatrie
|November 1, 1982
PubMed

Insights

Hormone resistance, where the body doesn't respond to hormones, can be genetic or acquired. These conditions, like pseudohypoparathyroidism, involve hormone systems with normal or high hormone secretion but low function.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Context:

  • Hormone resistance, first described in 1942, affects various endocrine systems.
  • Diseases include pseudohypoparathyroidism, impacting multiple hormone pathways.
  • Conditions can be congenital or acquired, with varying degrees of hormone unresponsiveness.

Purpose:

  • To review hormone resistance and unresponsiveness syndromes.
  • To highlight the role of receptor defects in congenital endocrinopathies.
  • To discuss the characteristics of hormone resistance.

Summary:

  • Hormone resistance involves unresponsiveness to peptide, steroid, and thyroid hormones.
  • Characterized by hypofunction despite normal or elevated hormone levels.
  • Pseudohypoparathyroidism type I exemplifies multi-systemic hormone resistance.

Impact:

  • Advances understanding of endocrine disorders.
  • Provides insights into genetic and acquired hormone resistance mechanisms.
  • Informs diagnosis and potential therapeutic strategies for hormone unresponsiveness.

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...